{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:17:30Z","timestamp":1778037450295,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Research Fund of Nanfang Hospital, Southern Medical University"},{"DOI":"10.13039\/501100021171","name":"GuangDong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04914-0","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:35:49Z","timestamp":1774622149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary macrophage migration inhibitory factor predicts kidney failure in advanced CKD patients"],"prefix":"10.1186","volume":"27","author":[{"given":"Xiaotian","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manqiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haocheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"4914_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/ki.2013.243","volume":"84","author":"KM Andrassy","year":"2013","unstructured":"Andrassy KM. Comments on \u2018KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u2019. Kidney Int. 2013;84:622\u20133. https:\/\/doi.org\/10.1038\/ki.2013.243.","journal-title":"Kidney Int"},{"key":"4914_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021;143:1157\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686.","journal-title":"Circulation"},{"key":"4914_CR3","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N. A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure. JAMA. 2011;305:1553. https:\/\/doi.org\/10.1001\/jama.2011.451.","journal-title":"JAMA"},{"key":"4914_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016;315:164. https:\/\/doi.org\/10.1001\/jama.2015.18202.","journal-title":"JAMA"},{"key":"4914_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1681\/ASN.2020071077","volume":"32","author":"CL Ramspek","year":"2021","unstructured":"Ramspek CL, Evans M, Wanner C, Drechsler C, Chesnaye NC, Szymczak M, et al. Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD. J Am Soc Nephrol. 2021;32:1174\u201386. https:\/\/doi.org\/10.1681\/ASN.2020071077.","journal-title":"J Am Soc Nephrol"},{"key":"4914_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrneph.2017.52","volume":"13","author":"C Zoccali","year":"2017","unstructured":"Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, et al. The systemic nature of CKD. Nat Rev Nephrol. 2017;13:344\u201358. https:\/\/doi.org\/10.1038\/nrneph.2017.52.","journal-title":"Nat Rev Nephrol"},{"key":"4914_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.ajkd.2018.09.012","volume":"73","author":"RL Amdur","year":"2019","unstructured":"Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, et al. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. Am J Kidney Dis. 2019;73:344\u201353. https:\/\/doi.org\/10.1053\/j.ajkd.2018.09.012.","journal-title":"Am J Kidney Dis"},{"key":"4914_CR8","doi-asserted-by":"publisher","unstructured":"Bruchfeld A, Wendt M, Miller EJ. Macrophage Migration Inhibitory Factor in Clinical Kidney Disease. Front Immunol. 2016;7. https:\/\/doi.org\/10.3389\/fimmu.2016.00008.","DOI":"10.3389\/fimmu.2016.00008"},{"key":"4914_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1248\/bpb.b12-00741","volume":"36","author":"T Watanabe","year":"2013","unstructured":"Watanabe T, Tomioka NH, Doshi M, Watanabe S, Tsuchiya M, Hosoyamada M. Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db\/db mice. Biol Pharm Bull. 2013;36:741\u20137. https:\/\/doi.org\/10.1248\/bpb.b12-00741.","journal-title":"Biol Pharm Bull"},{"key":"4914_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1358\/dnp.2010.23.4.1453629","volume":"23","author":"G Grieb","year":"2010","unstructured":"Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): A promising biomarker. Drug News Perspect. 2010;23:257. https:\/\/doi.org\/10.1358\/dnp.2010.23.4.1453629.","journal-title":"Drug News Perspect"},{"key":"4914_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2119\/molmed.2008.00109","volume":"15","author":"A Bruchfeld","year":"2009","unstructured":"Bruchfeld A, Carrero JJ, Qureshi AR, Lindholm B, Barany P, Heimburger O, et al. Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation. Mol Med. 2009;15:70\u20135. https:\/\/doi.org\/10.2119\/molmed.2008.00109.","journal-title":"Mol Med"},{"key":"4914_CR12","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1016\/j.ijcard.2013.08.021","volume":"168","author":"C Rammos","year":"2013","unstructured":"Rammos C, Hendgen-Cotta UB, Sobierajski J, Adamczyk S, Hetzel GR, Kleophas W, et al. Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease. Int J Cardiol. 2013;168:5249\u201356. https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.021.","journal-title":"Int J Cardiol"},{"key":"4914_CR13","first-page":"268","volume":"31","author":"A Foote","year":"2004","unstructured":"Foote A, Briganti EM, Kipen Y, Santos L, Leech M, Morand EF. Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol. 2004;31:268\u201373.","journal-title":"J Rheumatol"},{"key":"4914_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000046649","volume":"21","author":"K Matsumoto","year":"2001","unstructured":"Matsumoto K, Kanmatsuse K. Increased Production of Macrophage Migration Inhibitory Factor by T Cells in Patients with IgA Nephropathy. Am J Nephrol. 2001;21:455\u201364. https:\/\/doi.org\/10.1159\/000046649.","journal-title":"Am J Nephrol"},{"key":"4914_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/381358","volume":"2012","author":"M-Y Hong","year":"2012","unstructured":"Hong M-Y, Tseng C-C, Chuang C-C, Chen C-L, Lin S-H, Lin C-F. Urinary Macrophage Migration Inhibitory Factor Serves as a Potential Biomarker for Acute Kidney Injury in Patients with Acute Pyelonephritis. Mediat Inflamm. 2012;2012:1\u20139. https:\/\/doi.org\/10.1155\/2012\/381358.","journal-title":"Mediat Inflamm"},{"issue":"Suppl 1","key":"4914_CR16","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1681\/ASN.V13suppl_1s7","volume":"13","author":"FG Brown","year":"2002","unstructured":"Brown FG, Nikolic-Paterson DJ, Hill PA, Isbel NM, Dowling J, Metz CM, et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol. 2002;13(Suppl 1):S7\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"4914_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0009-9120(76)80054-9","volume":"9","author":"JC Mauck","year":"1976","unstructured":"Mauck JC. The quantitation of urinary and spinal fluid proteins by a modified biuret method. Clin Biochem. 1976;9:188\u201391. https:\/\/doi.org\/10.1016\/S0009-9120(76)80054-9.","journal-title":"Clin Biochem"},{"key":"4914_CR18","doi-asserted-by":"publisher","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y (Lucy), Castro AF, Feldman HI A New Equation to Estimate Glomerular Filtration Rate, et al. editors. Ann Intern Med. 2009;150:604. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"4914_CR19","doi-asserted-by":"publisher","first-page":"18558","DOI":"10.1038\/s41598-022-23440-1","volume":"12","author":"N Ding","year":"2022","unstructured":"Ding N, Li P-L, Wu K-L, Lv T-G, Yu W-L, Hao J. Macrophage migration inhibitory factor levels are associated with disease activity and possible complications in membranous nephropathy. Sci Rep. 2022;12:18558. https:\/\/doi.org\/10.1038\/s41598-022-23440-1.","journal-title":"Sci Rep"},{"key":"4914_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2174682","volume":"2016","author":"H Lu","year":"2016","unstructured":"Lu H, Bai Y, Wu L, Hong W, Liang Y, Chen B, et al. Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation and Matrix Deposition in Kidney Tissues after Injury. Mediat Inflamm. 2016;2016:1\u201312. https:\/\/doi.org\/10.1155\/2016\/2174682.","journal-title":"Mediat Inflamm"},{"key":"4914_CR21","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.3390\/jcm10214893","volume":"10","author":"K Musia\u0142","year":"2021","unstructured":"Musia\u0142 K, Zwoli\u0144ska D. Bone Morphogenetic Proteins (BMPs), Extracellular Matrix Metalloproteinases Inducer (EMMPRIN), and Macrophage Migration Inhibitory Factor (MIF): Usefulness in the Assessment of Tubular Dysfunction Related to Chronic Kidney Disease (CKD). JCM. 2021;10:4893. https:\/\/doi.org\/10.3390\/jcm10214893.","journal-title":"JCM"},{"key":"4914_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2215\/CJN.02780319","volume":"15","author":"R Malhotra","year":"2020","unstructured":"Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, et al. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. CJASN. 2020;15:349\u201358. https:\/\/doi.org\/10.2215\/CJN.02780319.","journal-title":"CJASN"},{"key":"4914_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1053\/j.ajkd.2021.01.021","volume":"78","author":"AL Bullen","year":"2021","unstructured":"Bullen AL, Katz R, Jotwani V, Garimella PS, Lee AK, Estrella MM, et al. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants. Am J Kidney Dis. 2021;78:361\u2013e3681. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.021.","journal-title":"Am J Kidney Dis"},{"key":"4914_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","volume":"91","author":"C Hsu","year":"2017","unstructured":"Hsu C, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, et al. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int. 2017;91:196\u2013203. https:\/\/doi.org\/10.1016\/j.kint.2016.09.003.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04914-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04914-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04914-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:03:23Z","timestamp":1778036603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04914-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4914"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04914-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the National Clinical Research Center for Kidney Disease (NFEC-2019-094). This study was carried out in accordance with the code of ethics of the World Medical Association Declaration of Helsinki, and patients or the next of kin of the patients were informed and gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}